TPPP3 and lung cancer: Comparing to normal tissues, the study demonstrated that TPPP3 observed lower expression in bladder cancer, brain cancer, breast cancer, head and neck cancer, kidney cancer, lung cancer, melanoma, ovarian cancer, and sarcoma and high expression in gastric cancer (Figure 1(a)).